denileukin diftitox
Sign in to saveAlso known as Ontak, DAB389 IL2, DT, NAD(+--diphthamide ADP- ribosyltransferase), Diphtheria toxin precursor, denileukin
pharmaceutical drug
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Protein
- First approval
- 1999
- Admin. routes
- parenteral
- Indications
- multiple myeloma, melanoma, pancreatic carcinoma, neoplasm
via ChEMBL · EBI
Research
300 papers- Denileukin Diftitox.2006
- Denileukin Diftitox.2012
- Denileukin diftitox.American journal of clinical dermatology · 2000
- Denileukin diftitox: a novel immunotoxin.Expert opinion on biological therapy · 2009
- Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Has use
- medication
Show 2 more facts
- subject has role
- antineoplastic
- has characteristic
- biopharmaceutical
via Wikidata · CC0
Available in 10 languages
via Wikidata sitelinks · CC0